As proof of concept that Cbl-b may serve as a novel cancer immunotherapy target, we have already shown that adoptive transfer of Cblb-silenced polyclonal CD8+ T cells together with DC vaccination resulted in strong suppression of tumor growth with substantially prolonged overall survival, interestingly without any sign of autoimmunity [35]. Here, CD8A is linked to cancer.